As a result of our research, we have concluded that dCK might be a new therapeutic target for increasing the radiosensitivity of HeLa cells and that HSP90 inhibitors might help to increase the effectiveness of radiation therapy for cervical cancer. This evidence concerns the gene HSP90AA1 and cervical carcinoma.